---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-087368"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:42:06.654304+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aptevo Therapeutics enters $25M standby equity purchase agreement with Yorkville

## Summary
- Up to $25M in common stock may be sold to YA II PN over 36 months at 96% of lowest 3-day VWAP.
- Exchange cap of 151,755 shares (19.99% of outstanding) unless stockholder approval or avg price ≥ $3.66.
- Yorkville's beneficial ownership limited to 9.99% of outstanding shares.
- Structuring fee of $25,000 paid; commitment fee of 2% of commitment amount in five quarterly installments.
- Advance subject to filing and effectiveness of registration statement with the SEC.

## SEC filing metadata
- accession: 0000950170-25-087368
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/0000950170-25-087368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025087368/apvo-20250616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-087368
- JSON: https://secwatch.observer/filing/0000950170-25-087368.json
- Plain text: https://secwatch.observer/filing/0000950170-25-087368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.